🎉 Big news! #TargetRWE is proud to announce our acquisition by Highlander Health, led by industry trailblazers Dr. Amy Abernethy and Dr. Brad Hirsch, aimed to modernize #ClinicalEvidence generation & improve personalized care for patients. Link 👉 https://t.co/60Rkje08vp

🗣️ Heading to #EASL2025? So is Target RWE's Dr. Michael W. Fried! We're sharing our expertise in #Hepatology. Click for our latest #EASLCongress2025: #RWE

Discover the future of evidence generation at #ISPOR2025 with #TargetRWE. Our expertise in #RWD and advanced analytics delivers critical insights for better healthcare. Let's connect in Montreal! 💡 https://t.co/WRh1XWAnEp #RWEAnalysis #HealthcareInnovation

Unlock robust #RWE with #TargetRWE at #ISPOR2025. Our data-agnostic approach & deep expertise deliver meaningful insights. Let's connect 🔗 https://t.co/xScThAM92B #RealWorldEvidence #Research #DataScience

Amsterdam is calling! 🇳🇱✈️ Join Target RWE at #EASL2025 to explore #RealWorldEvidence in #LiverDisease. We're presenting key MASH & HCC research! Meet us there: https://t.co/u0eyz2rOFl #Hepatology #MASH #HCC #RWE #EASL2025

🚨 #TargetRWE is heading to #EASL2025 in Amsterdam next month! We’ll present groundbreaking research on disease progression and treatment in #MASH & #HCC patients using #RealWorldEvidence to enhance #LiverDisease understanding. 📅 Schedule a meeting: https://t.co/kJYFP2xQZj

📢 See you at #DDW2025! #TargetRWE is excited to connect with industry leaders in San Diego to explore advancements in #GIResearch. Let's talk #RealWorldEvidence! 📅 Meet with us: https://t.co/q3En5HCB8E #Gastroenterology #RWE #RWD

📢📝 Applications are OPEN for the TARGET-LD & CQC Data Registry! Join the #TARGETLD program and help advance the #AASLD's #CirrhosisQualityCollaborative (#CQC) with real-world #LiverDisease data for research. Don’t miss your chance—apply today! 🔗 https://t.co/6pMmeg8wew

📊📚 Check out #TargetRWE’s latest study on #HCC patients! 𝘋𝘈𝘈-𝘗𝘈𝘚𝘚 explores the risk of HCC recurrence after Direct-Acting Antiviral (DAA) therapy. The study shows DAA doesn’t increase recurrence risk in patients with a prior complete response: https://t.co/eKnhmm2WZk

🎥📈 Missed #TargetRWE's #ACG2024 research? Watch Dr. Evan S. Dellon, MD, MPH, dive into our study on Eosinophilic Esophagitis (EoE) treatment patterns. He explores why some diagnosed patients aren't receiving medication. Don’t miss these key insights: https://t.co/efwkznY7pd

📱 #TargetRWE's engage™ platform is revolutionizing patient & clinician data collection! Simplify #PatientReportedOutcome & #ClinicianReportedOutcome Measures with real-time insights, flexible data collection, and incentivized adherence. For more: https://t.co/qY3n7SQsvh

🌐 Dive into #TargetRWE’s real-world #GastroenterologyData! We're turning clinical data into actionable insights for #GIDiseases. From simple observations to complex analyses, our data delivers. Explore more: https://t.co/JkPjtEvqft #RWE #HealthcareInnovation #GastroCare

🚀 At #TargetRWE, we help you harness the power of #RealWorldData to generate high-quality evidence. Our team offers support for #StudyDesign, from basic stats to advanced R programming. Lets elevate your #ResearchOutcomes! 📈 https://t.co/bcWaGx7T2Y

#TARGETLD is leading the way in #Hepatology, uniting top investigators & sites to create the largest #LiverResearchConsortium. Collaborate with experts and drive innovations that shape #LiverDisease management & #PatientCare. Learn more: https://t.co/5SA1sa4nF4

🚀 At #TargetRWE, we're transforming clinical research with #RealWorldEvidence! Our #ResearchPublications offer valuable insights into various diseases, driving innovations in healthcare. See how we're improving #PatientOutcomes: https://t.co/l33c3eYQ3l #ClinicalResearch

Today, on #InternationalWomensDay, we celebrate the incredible contributions of women in #hepatology. From pioneering research to patient care, their dedication is shaping the future of #liver health. #IWD2025

March is National #ColorectalCancerAwarenessMonth! Join us at #DDW2025 and get in the fight against #CRC. Learn how we will support you with the updates you need this year:

At #ACG2024, Dr. A. Sidney Barritt IV from #TargetRWE presented on SGLT2i & DPP4i for metabolic dysfunction-associated steatohepatitis (MASH) 🧑‍⚕️💊. 📊 Explore their potential benefits in #MASH management. Watch the presentation here: https://t.co/pZaBszCntW #SGLT2i #DPP4i

🌍 Happy #InternationalDayofWomenandGirlsinScience! Today, we celebrate the amazing women driving innovation in science. At #TargetRWE, we're proud to work alongside these trailblazers shaping the future of #Healthcare through #RealWorldEvidence. #DiversityInScience #IDWGS2025

🚀 Transforming healthcare with data-driven #RealWorldEvidence since 2015! 🌍 At #TargetRWE, we enhance #DrugDevelopment & #PatientOutcomes at every stage. Discover our proven #RWESolutions: https://t.co/WYpVaXjBY1 #ClinicalResearch #RWD #RWE #ProductDevelopment

High-energy week at #TargetRWE! 🚀 We had a fantastic all-hands meeting hosted by Highlander Health. From insightful discussions to a mini-hackathon, we tackled key challenges and aligned on critical objectives. Thanks to everyone for their contributions! #RealWorldEvidence